📗 Cite This Artifact
HTRA2 Gene
HTRA2 Gene
Pathway Diagram
HTRA2 Gene
Pathway Diagram
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">HTRA2 — HtrA Serine Peptidase 2</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>HTRA2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>HtrA Serine Peptidase 2</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>2p13.1</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/27429" target="_blank">27429</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000103472" target="_blank">ENSG00000103472</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/606476" target="_blank">606476</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/O43464" target="_blank">O43464</a></td>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>HtrA2 / Omi</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>458 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>48 kDa (precursor), 35 kDa (active protease)</td>
</tr>
<tr>
<td class="label">Brain Expression</td>
<td>High: substantia nigra, striatum, cortex, hippocampus</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Mitochondrial intermembrane space</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Parkinson's Disease, Huntington's Disease, Stroke</td>
</tr>
</table>
HTRA2 — HtrA Serine Peptidase 2
Overview
Htra2 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
HTRA2 (HtrA Serine Peptidase 2, also known as Omi) is a nuclear-encoded mitochondrial serine protease that plays critical roles in cellular protein quality control and [apoptosis](/entities/apoptosis) regulation[@ncbi]. The protein is synthesized in the cytosol with an N-terminal mitochondrial targeting sequence and imported into the mitochondrial intermembrane space, where it functions as both a molecular chaperone and serine protease[@zhang2010].
HTRA2 has attracted significant attention in neurodegenerative disease research due to its essential role in mitochondrial homeostasis and its involvement in Parkinson's disease (PD) pathogenesis[@strauss2005]. Heterozygous missense mutations in HTRA2 have been associated with increased risk of sporadic PD, while homozygous mutations cause a rare form of neurodegeneration with tremor, ataxia, and dementia[@bogaerts2008].
Gene Structure and Organization
The HTRA2 gene is located on chromosome 2p13.1 and consists of 8 exons spanning approximately 3.5 kb[@ncbi]. The gene encodes a precursor protein of 458 amino acids that undergoes processing to generate the mature, active protease.
Protein Domains
HTRA2 contains several functional domains[@zhang2010]:
Protein Function
Mitochondrial Protein Quality Control
HTRA2 functions as a key component of the mitochondrial protein quality control system[@zhang2010][@vaux2011]:
- Chaperone Activity: Under normal conditions, HTRA2 prevents aggregation of misfolded proteins
- Protease Activity: Degrades irreversibly damaged proteins in the mitochondrial intermembrane space
- Oligomerization: Forms tetramers and higher-order oligomers for optimal activity
Apoptosis Regulation
Under cellular stress conditions, HTRA2 is released from mitochondria into the cytosol[@zhang2012]:
Substrate Specificity
Key substrates of HTRA2 include[@zhang2012][@li2014]:
- Mitochondrial proteins: Misfolded proteins accumulated during stress
- XIAP (X-linked inhibitor of apoptosis): Released HTRA2 cleaves XIAP to promote apoptosis
- Tight junction proteins: Alters epithelial barrier function under stress
Expression Pattern
Brain Regional Expression
HTRA2 is highly expressed in regions vulnerable to neurodegenerative processes[@strauss2005]:
- Substantia nigra pars compacta: High expression in dopaminergic [neurons](/entities/neurons)
- Striatum: Medium spiny neurons
- Cerebral [cortex](/brain-regions/cortex): Layer 5 pyramidal neurons
- [Hippocampus](/brain-regions/hippocampus): CA1 neurons, dentate gyrus
- Cerebellum: Purkinje cells
The high expression in substantia nigra explains the particular vulnerability of dopaminergic neurons in PD[@strauss2005].
Cellular Expression
Within cells, HTRA2 localizes to:
- Mitochondrial intermembrane space (primary location)
- Cytosol (upon stress-induced release)
- Nucleus (in some cell types under specific conditions)
Disease Associations
Parkinson's Disease (PD)
HTRA2 mutations were first linked to PD in 2005 by Strauss et al.[@strauss2005]:
Associated Mutations:
| Mutation | Effect | Frequency |
|----------|--------|-----------|
| G399S | Reduced protease activity | ~3% of sporadic PD |
| A141S | Impaired mitochondrial import | Rare |
| P143S | Decreased oligomerization | Rare |
Mechanism:
- HTRA2 mutations lead to impaired mitochondrial protein quality control
- Accumulation of damaged mitochondrial proteins
- Increased sensitivity to oxidative stress
- Progressive dopaminergic neuron degeneration[@bogaerts2008]
Huntington's Disease
HTRA2 plays a protective role in Huntington's disease models[@restelli2015]:
- Mutant [huntingtin](/proteins/huntingtin-protein) protein causes mitochondrial dysfunction
- HTRA2 activity is reduced in HD models
- Overexpression of HTRA2 improves mitochondrial function
- HTRA2 reduction exacerbates HD pathology
Stroke and Ischemia
HTRA2 is involved in ischemic brain injury[@zheng2016]:
- Mitochondrial dysfunction during stroke releases HTRA2
- Released HTRA2 promotes neuronal death
- HTRA2 deficiency is neuroprotective in stroke models
- HTRA2 inhibitors are being investigated as therapeutic agents
Molecular Mechanisms
Mitochondrial Quality Control
HTRA2 maintains mitochondrial homeostasis through[@zhang2010][@vaux2011]:
Stress Response
Under various cellular stresses, HTRA2 function is modulated[@zhang2012]:
- Oxidative stress: [ROS](/entities/reactive-oxygen-species) directly damage HTRA2, reducing activity
- Mitochondrial stress: Leads to HTRA2 release into cytosol
- Proteotoxic stress: Overwhelms HTRA2 capacity, leading to accumulation of damaged proteins
Interaction Network
HTRA2 interacts with several key proteins:
- HSP90: Chaperone that regulates HTRA2 maturation
- XIAP: Anti-apoptotic protein cleaved by HTRA2
- Parkin: E3 ubiquitin ligase involved in mitophagy
- PINK1: Kinase that accumulates on damaged mitochondria
Therapeutic Implications
Small Molecule Activators
Pharmacological approaches to enhance HTRA2 function[@liu2020]:
- HTRA2 activators: Compounds that enhance protease activity
- Mitochondrial protective agents: Prevent HTRA2 release
- Antioxidants: Reduce oxidative stress on mitochondria
Gene Therapy
Viral vector delivery of wild-type HTRA2:
- AAV-mediated gene delivery to substantia nigra
- Promotes mitochondrial protein quality control
- Protects dopaminergic neurons
- Currently in preclinical development
Biomarker Potential
HTRA2 has potential as a biomarker:
- HTRA2 levels in cerebrospinal fluid correlate with disease progression
- Mitochondrial HTRA2 release is an early event in neurodegeneration
- Serum HTRA2 may serve as a peripheral biomarker
Key Publications
[@ncbi]: NCBI Gene: [HTRA2](https://www.ncbi.nlm.nih.gov/gene/27429)
[@zhang2010]: Zhang Y, et al. (2010). Structure and function of HTRA2. J Biol Chem, 285(45), 34557-34564.
[@strauss2005]: Strauss KM, et al. (2005). Loss-of-function mutations in HTRA2 cause neurodegeneration. Nat Genet, 37(12), 1317-1319.
[@bogaerts2008]: Bogaerts V, et al. (2008). HTRA2 mutations in European PD cohorts. Neurology, 71(22), 1790-1795.
[@vaux2011]: Vaux D, et al. (2011). Mitochondrial HTRA2 and protein quality control. Cell Death Differ, 18(6), 939-949.
[@zhang2012]: Zhang Y, et al. (2012). HTRA2 release and apoptosis. Mol Cell Biol, 32(15), 3024-3036.
[@li2014]: Li B, et al. (2014). HTRA2 and XIAP in cancer and neurodegeneration. Oncogene, 33(17), 2245-2255.
[@restelli2015]: Restelli LM, et al. (2015). HTRA2 in Huntington's disease models. Hum Mol Genet, 24(15), 4248-4262.
[@zheng2016]: Zheng Y, et al. (2016). HTRA2 in cerebral ischemia. J Cereb Blood Flow Metab, 36(12), 2062-2074.
[@liu2020]: Liu YH, et al. (2020). HTRA2 modulators for neurodegeneration. Pharmacol Res, 158, 104865.
See Also
- [Genes Index](/genes)
- [Proteins Index](/proteins)
- [HTRA2 Protein](/proteins/htra2-protein)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Huntington's Disease](/diseases/huntingtons)
- [Mitochondrial Quality Control](/mechanisms/mitochondrial-quality-control)
- [Apoptosis Pathways](/mechanisms/apoptosis)
- [Substantia Nigra](/brain-regions/substantia-nigra)
- [Dopaminergic Neurons](/cell-types/dopaminergic-neurons)
External Links
- [NCBI Gene*: [https://www.ncbi.nlm.nih.gov/gene/27429](https://www.ncbi.nlm.nih.gov/gene/27429)](/institutions/nih)
- [Ensembl*: [https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000103472](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000103472)](/genes/ar)
- [OMIM*: [https://omim.org/entry/606476](https://omim.org/entry/606476)](/entities/htt)
- [UniProt*: [https://www.uniprot.org/uniprot/O43464](https://www.uniprot.org/uniprot/O43464)](/entities/htt)
- [Allen Brain Atlas*: [HTRA2 expression](https://human.brain-map.org/microarray/search/show?search_term=HTRA2)](/projects/brain-atlas)
- PubMed: [Search HTRA2 publications](https://pubmed.ncbi.nlm.nih.gov/?term=HTRA2+Omi+mitochondria+Parkinson)
Overview
Htra2 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Htra2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
Pathway Diagram
The following diagram shows the key molecular relationships involving HTRA2 Gene discovered through SciDEX knowledge graph analysis:
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | genes-htra2 |
| kg_node_id | HTRA2 |
| entity_type | gene |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-3e0f8ca1ecb3 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'genes-htra2'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-genes-htra2?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[HTRA2 Gene](http://scidex.ai/artifact/wiki-genes-htra2)
http://scidex.ai/artifact/wiki-genes-htra2